| Title: | Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study |
| Journal: | Brain Behavior and Immunity |
| Published: | 24 Oct 2020 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/33148439/ |
| DOI: | https://doi.org/10.1016/j.bbi.2020.10.019 |
Publication 4535
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
INTRODUCTION: Our understanding of risk factors for COVID-19, including pre-existing medical conditions and genetic variations, is limited. To what extent the pre-existing clinical condition and genetic background have implications for COVID-19 still needs to be explored.</p>
METHODS: Our study included 389,620 participants of European descent from the UK Biobank, of whom 3,884 received the COVID-19 test and 1,091 were tested positive for COVID-19. We examined the association of COVID-19 status with an extensive list of 974 medical conditions and 30 blood biomarkers. Additionally, we tested the association of genetic variants in two key genes related to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2), with COVID-19 or any other phenotypes.</p>
RESULTS: The most significant risk factors for COVID-19 include Alzheimer's disease (OR = 2.29, 95% CI: 1.25-4.16), dementia (OR = 2.16, 95% CI: 1.36-3.42), and the overall category of delirium, dementia, amnestic and other cognitive disorders (OR = 1.90, 95% CI: 1.24-2.90). Evidence suggesting associations of genetic variants in SARS-CoV-2 infection-related genes with COVID-19 (rs7282236, OR = 1.33, 95% CI: 1.14-1.54, p = 2.31 × 10-4) and other phenotypes, such as an immune deficiency (p = 5.65 × 10-5) and prostate cancer (p = 1.1 × 10-5), was obtained.</p>
CONCLUSIONS: Our unbiased and extensive search identified pre-existing Alzheimer's disease and dementia as top risk factors for hospital admission due to COVID-19, highlighting the importance of providing special protective care for patients with cognitive disorders during this pandemic. We also obtained evidence suggesting a direct association of genetic variants with COVID-19.</p>
18 Keywords
- Adult
- Aged
- Angiotensin-Converting Enzyme 2
- Biomarkers
- COVID-19
- Cognition
- Cognitive Dysfunction
- Cohort Studies
- Female
- Hospitalization
- Humans
- Male
- Middle Aged
- Pandemics
- Risk Factors
- SARS-CoV-2
- Serine Endopeptidases
- White People
5 Authors
- Jingqi Zhou
- Chang Liu
- Yitang Sun
- Weishan Huang
- Kaixiong Ye
1 Application
| Application ID | Title |
|---|---|
| 48818 | Evaluate the causal effects of diet-modifiable biomarkers on clinical outcomes using Mendelian randomization |
Enabling scientific discoveries that improve human health